Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNQ2 | O43526 | 7/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.63 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.63 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.63 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.63 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2761225 | 1.00 | KCNQ2 (1.00) | KCNQ2CYP3A4ALOX15TSHRCYP1A2 | |
| Hydrochloric Acid SCHEMBL27203219 | 0.98 | KCNQ2 (0.97) | KCNQ2CYP3A4ALOX15TSHRCYP1A2 | |
| SCHEMBL13002451 | 0.91 | KCNQ2 (0.82) | KCNQ2CYP3A4ALOX15TSHRCYP1A2 | |
| SCHEMBL9261740 | 0.89 | KCNQ2 (0.79) | KCNQ2CYP3A4ALOX15TSHRCYP1A2 | |
| Hydrochloric Acid SCHEMBL9265822 | 0.87 | KCNQ2 (0.77) | KCNQ2CYP3A4ALOX15TSHRCYP1A2 | |
| SCHEMBL7358470 | 0.86 | KCNQ2 (0.90) | KCNQ2CYP3A4ALOX15TSHRCYP1A2 | |
| SCHEMBL31476412 | 0.85 | KCNQ2 (0.73) | KCNQ2CYP3A4ALOX15TSHRCYP1A2 | |
| SCHEMBL7547211 | 0.85 | KCNQ2 (0.73) | KCNQ2CYP3A4ALOX15TSHRCYP1A2 | |
| SCHEMBL9378991 | 0.81 | KCNQ2 (0.68) | KCNQ2CYP3A4ALOX15TSHRCYP1A2 | |
| SCHEMBL9376535 | 0.81 | KCNQ2 (0.68) | KCNQ2CYP3A4ALOX15TSHRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709708-A1 | NOVEL CARBOXAMIDE DERIVATIVES | ANGELINI PHARMA S.P.A. (IT) | 2026-03-18 | — | — | EP | disclosed |
| CN-121586775-A | Voltage-gated sodium channel-specific peptide aptamer and application thereof | 威斯康星州医药大学股份有限公司 | 2026-02-27 | — | — | CN | disclosed |
| EP-4695399-A2 | VOLTAGE GATED SODIUM CHANNEL-SPECIFIC PEPTIDE APTAMERS AND USES THEREOF | The Medical College of Wisconsin, Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| US-12533425-B2 | Methods and systems using peptides for targeting and mapping human nerves in image guided surgery, diagnostics and therapeutic delivery | ALUME BIOSCIENCES, INC. (US) | 2026-01-27 | — | — | US | disclosed |
| US-20260003178-A1 | MICROSCOPE WITH SPATIAL IMAGING AND BEAM HOMOGENIZER | QUIVER HOLDINGS INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12508239-B2 | Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizures | H. LUNDBECK A/S (DK) | 2025-12-30 | — | — | US | disclosed |
| WO-2025227157-A1 | MODIFIED CELLS AND USES THEREOF | UNIVERSITY OF MIAMI (US) | 2025-10-30 | — | — | WO | disclosed |
| US-12422660-B2 | Microscope for imaging samples within wells of multi-well plates hold by stage and beam homogenizer for homogenizing beam | QUIVER HOLDINGS INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-20250282725-A1 | KCNQ POTENTIATORS | Eii Lilly and Company | 2025-09-11 | — | — | US | disclosed |
| EP-4584250-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | Biohaven Therapeutics Ltd. (VG) | 2025-07-16 | — | — | EP | disclosed |
| CN-108884030-B | Improved labeling of nucleophiles using bipyridines | 安捷伦科技有限公司 | 2022-06-28 | — | — | CN | disclosed |
| WO-2022120177-A1 | NERVE TARGETING PEPTIDES AND METHODS OF USE | ALUME BIOSCIENCES, INC. (US) | 2022-06-09 | — | — | WO | disclosed |
| EP-4007571-A1 | ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS FOR USE IN EPILEPSY OR SEIZURES | H. Lundbeck A/S (DK) | 2022-06-08 | — | — | EP | disclosed |
| EP-4007634-A1 | ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS | H. Lundbeck A/S (DK) | 2022-06-08 | — | — | EP | disclosed |
| US-11299515-B2 | Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-12 | — | — | US | disclosed |
| CN-114206328-A | Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizures | H.隆德贝克有限公司 | 2022-03-18 | — | — | CN | disclosed |
| CN-114206830-A | Alcohol derivatives as Kv7 potassium channel openers | H.隆德贝克有限公司 | 2022-03-18 | — | — | CN | disclosed |
| US-20220073464-A1 | KCNQ POTENTIATORS | ELI LILLY AND COMPANY | 2022-03-10 | — | — | US | disclosed |
| US-20220054499-A1 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2022-02-24 | — | — | US | disclosed |
| US-20220040095-A1 | AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS | DOMPÉ FARMACEUTICI S.P.A. (IT) | 2022-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282725-A1 | KCNQ POTENTIATORS | KCNN3, KCNQ1, KCNN1 | KCNQ2 5/4885CYP3A4 2954/4885ALOX15 2723/4885 |
| US-20260003178-A1 | MICROSCOPE WITH SPATIAL IMAGING AND BEAM HOMOGENIZER | MYO1F, ASF1A, WASF2 | KCNQ2 2184/4885CYP3A4 4699/4885ALOX15 4159/4885 |
| US-20220054499-A1 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | MKI67, MYLK2, MYH2 | KCNQ2 4607/4885CYP3A4 4880/4885ALOX15 3805/4885 |
| US-12533425-B2 | Methods and systems using peptides for targeting and mapping human nerves in image guided surgery, diagnostics and therapeutic delivery | NGLY1, VGF, GAP43 | KCNQ2 1234/4885CYP3A4 4828/4885ALOX15 4559/4885 |
| US-20220073464-A1 | KCNQ POTENTIATORS | KCNN3, KCNQ1, KCNN1 | KCNQ2 5/4885CYP3A4 2954/4885ALOX15 2723/4885 |
| US-20220040095-A1 | AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS | OTC, AQP4, SLC26A4 | KCNQ2 2082/4885CYP3A4 4486/4885ALOX15 462/4885 |
| US-12508239-B2 | Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizures | KCNN3, KCNN1, KCNN2 | KCNQ2 6/4885CYP3A4 3532/4885ALOX15 2730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.